Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers

Journal of Viral Hepatitis

Volumn 8, Issue 4, 2001, Pages 256-263

  Yeo, A E T ^a,b,c   Ghany, M ^a,b,c   Conry Cantilena, C ^a,b,c   Melpolder, J C ^a,b,c   Kleiner, D E ^a,b,c   Shih, J W K ^a,b,c   Hoofnagle, J H ^a,b,c   Alter, H J ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hepatitis C virus; Liver histology

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; VIRUS RNA;

ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; ALANINE TRANSAMINASE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RNA, VIRAL;

EID: 0034918152     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00302.x     Document Type: Article

References (42)

1. Chronic consequences of non-A, non-B hepatitis
2. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy
3. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with hepatitis C chronic liver disease
4. Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C
5. Rapid and precise quantification of HIV-1 RNA in-plasma using a branched DNA signal amplification assay
6. Volunteer blood donors with antibody to hepatitis C virus: Clinical biochemical, virologic, and histologic features
7. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
8. Reverse transcriptase-PCR for hepatitis C virus RNA
9. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
10. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
11. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction
12. Quantitation of hepatitis C genome molecules in the plasma samples
13. A new step toward standardization of serum hepatitis C virus RNA quantification in patients with chronic hepatitis C
14. Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C RNA quantification as measured with branched-DNA technology
15. Detection of the replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells
16. Infection of peripheral blood mononuclear cells by hepatitis C virus
17. B-Lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV)
18. Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C
19. Hepatitis C virus: Quantitation and distribution in liver
20. Serum HCV-RNA levels assessed by quantitative NASBA®: Stability of viral load over time, and lack of correlation with liver disease
21. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification
22. The clinical spectrum of disease
23. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
24. Serum and liver HCV RNA levels in patients with chronic hepatitis C. correlation with clinical and histological features
25. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease
26. Serum hepatitis C virus RNA quantity and histological features of hepatitis C carriers with persistently normal ALT levels
27. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
28. Assessment of hepatitis C virus RNA levels by competitive RNA polymerase chain reaction: High titer viremia correlates with advanced stage of disease
29. HCV-RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury
30. Involvement of FAS system-mediated apoptosis in pathogenesis of viral hepatitis
31. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
32. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infection
33. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
34. Role of the specific T-cell response for clearance and control of hepatitis C virus
35. Cellular immune response to the hepatitis C virus
36. Virus-host interaction in chronic hepatitis B infection
37. Hepatitis C virus genotypes are not responsible for the development of serious liver disease
38. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States
39. Severity of liver disease with different hepatitis C viral clones
40. Clinical backgrounds of the patients having different types of hepatitis C genomes
41. Hepatitis C virus type 1b (II) infection in France and Italy
42. The natural course of chronic hepatitis C. A comparison between patients with genotype 1 and 2 hepatitis C viruses